LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

Home・Aktien・Laboratory Corp of America Holdings

Laboratory Corp of America Holdings

Geschlossen

BrancheGesundheitswesen

257.02 0.79

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

253.16

Max

258.55

Schlüsselkennzahlen
By Trading Economics
Einkommen	113M 278M
Verkäufe	22M 3.5B
KGV Branchendurchschnitt	22.43 49.8
EPS	4.25
Dividendenrendite	1.13
Gewinnspanne	7.858
Angestellte	71,000
EBITDA	142M 561M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+21.84% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.13% 2.25%
Nächstes Ergebnis	23. Juli 2026
Nächste Dividendenausschüttung	11. Juni 2026
Nächstes Ex-Dividendendatum	29. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-884M 21B
Vorheriger Eröffnungskurs	256.23
Vorheriger Schlusskurs	257.02

Nachrichtenstimmung

By Acuity

50%

150 / 346 Ranking in Healthcare

Laboratory Corp of America Holdings Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Laboratory Corp of America Holdings Prognose

Kursziel

By TipRanks

21.84% Vorteil

12-Monats-Prognose

Durchschnitt 310.78 USD 21.84%

Hoch 334 USD

Tief 290 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Laboratory Corp of America Holdings – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Laboratory Corp of America Holdings – Dist abgegeben haben.

Stimmung

By Acuity

150 / 346 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.